These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35125420)

  • 21. Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Response.
    Bidot S; Bruce BB; Saindane AM; Newman NJ; Biousse V
    J Neuroophthalmol; 2015 Sep; 35(3):331. PubMed ID: 26218626
    [No Abstract]   [Full Text] [Related]  

  • 22. Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Comment.
    Killer HE
    J Neuroophthalmol; 2015 Sep; 35(3):330-1. PubMed ID: 26196848
    [No Abstract]   [Full Text] [Related]  

  • 23. Idiopathic intracranial hypertension in a transgender female.
    Sigireddi RR; Lyons LJ; Lee AG
    Can J Ophthalmol; 2019 Feb; 54(1):e35-e38. PubMed ID: 30851796
    [No Abstract]   [Full Text] [Related]  

  • 24. Pseudo-Foster Kennedy syndrome due to idiopathic intracranial hypertension.
    Micieli JA; Al-Obthani M; Sundaram AN
    Can J Ophthalmol; 2014 Aug; 49(4):e99-e102. PubMed ID: 25103671
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis and treatment of idiopathic intracranial hypertension.
    Raoof N; Hoffmann J
    Cephalalgia; 2021 Apr; 41(4):472-478. PubMed ID: 33631966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI of optic disc edema in childhood idiopathic intracranial hypertension.
    Mandelstam S; Moon A
    Pediatr Radiol; 2004 Apr; 34(4):362. PubMed ID: 14722694
    [No Abstract]   [Full Text] [Related]  

  • 27. Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases.
    Brun BN; Aylward SC
    Semin Pediatr Neurol; 2021 Dec; 40():100922. PubMed ID: 34749916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlap and Differences in Migraine and Idiopathic Intracranial Hypertension.
    Sengupta S; Vidwan J
    Curr Pain Headache Rep; 2023 Nov; 27(11):653-662. PubMed ID: 37656318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic Intracranial Hypertension Without Papilledema With Improvement in Visual Field Defect Following Optic Nerve Sheath Fenestration: Response.
    Scofield-Kaplan SM; Patel KG; Jones FR; Hogan RN
    J Neuroophthalmol; 2021 Mar; 41(1):135-136. PubMed ID: 32358437
    [No Abstract]   [Full Text] [Related]  

  • 30. Idiopathic Intracranial Hypertension Without Papilledema With Improvement in Visual Field Defect Following Optic Nerve Sheath Fenestration: Comment.
    Margolin E
    J Neuroophthalmol; 2021 Mar; 41(1):135. PubMed ID: 32358434
    [No Abstract]   [Full Text] [Related]  

  • 31. Papilledema: A review of etiology, pathophysiology, diagnosis, and management.
    Xie JS; Donaldson L; Margolin E
    Surv Ophthalmol; 2022; 67(4):1135-1159. PubMed ID: 34813854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension.
    Knoche T; Gaus V; Haffner P; Kowski A
    Neurol Sci; 2023 Jun; 44(6):2131-2135. PubMed ID: 36689008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should Acetazolamide Be the First-Line Treatment for Patients With Idiopathic Intracranial Hypertension?
    Kaufman DI; Friedman DI
    J Neuroophthalmol; 2017 Jun; 37(2):182-186. PubMed ID: 28376023
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pseudotumor cerebri or idiopathic cranial hypertension. Neuro-ophthalmologic considerations].
    Roşca T
    Oftalmologia; 2002; 54(3):11-3. PubMed ID: 12723189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral papilledema in 'benign' intracranial hypertension (pseudotumor cerebri).
    Sher NA; Wirtschafter J; Shapiro SK; See C; Shapiro I
    JAMA; 1983 Nov; 250(17):2346-7. PubMed ID: 6632132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axonal damage in papilledema linked to idiopathic intracranial hypertension as revealed by multifocal visual evoked potentials.
    Hartmann CJ; Klistorner AI; Brandt AU; Schroeder K; Kolbe R; Cohn E; Goebels N; Guthoff R; Aktas O; Hartung HP; Albrecht P
    Clin Neurophysiol; 2015 Oct; 126(10):2040-1. PubMed ID: 25613033
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term evolution of papilledema in idiopathic intracranial hypertension: observations concerning two cases.
    Piovesan EJ; Lange MC; Piovesan Ldo R; de Almeida SM; Kowacs PA; Werneck LC
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):453-7. PubMed ID: 12131949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic Intracranial Hypertension: A Case Report.
    Ghimire A; Acharya AR; Karn A; Kumar Jha M
    JNMA J Nepal Med Assoc; 2021 Feb; 59(234):197-199. PubMed ID: 34506475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unilateral papilledema in pseudotumor cerebri.
    Brosh K; Strassman I
    Semin Ophthalmol; 2013 Jul; 28(4):242-3. PubMed ID: 23627435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic intracranial hypertension without papilloedema in headache sufferers.
    Bono F; Quattrone A
    Cephalalgia; 2009 May; 29(5):593; author reply 594. PubMed ID: 19170702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.